Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P King

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
IRB|October 23, 2003
Assessing benefits in clinical research: why diversity in benefit assessment can be riskyLarry R Churchill, Daniel K Nelson, Gail E Henderson, et al.
Clinical Pharmacology and Therapeutics|November 24, 2025
Biomarkers of Drug-Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug DevelopmentTanja S Zabka, Michael Lawton, Tom Chu, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
The Journal of Biological Chemistry|December 10, 2000
Subunit II of cytochrome c oxidase in Chlamydomonad algae is a heterodimer encoded by two independent nuclear genesX Pérez-Martínez, A Antaramian, M Vazquez-Acevedo, et al.
Circulation|July 9, 2004
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathySherif F Nagueh, Gopi Shah, Yiming Wu, et al.
Social Science & Medicine (1982)|July 8, 2005
Therapeutic misconception in early phase gene transfer trialsGail E Henderson, Michele M Easter, Catherine Zimmer, et al.
Database : the Journal of Biological Databases and Curation|February 2, 2026
predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugsJens Hansen, Pedro Martinez, Arjun S Yadaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Uncertain benefit: investigators' views and communications in early phase gene transfer trialsGail E Henderson, Arlene M Davis, Nancy M P King, et al.
American Journal of Nephrology|November 28, 2013
Perceptions regarding genetic testing in populations at risk for nephropathyBarry I Freedman, Alison J Fletcher, Vivek R Sanghani, et al.
Journal of Pharmacological and Toxicological Methods|October 31, 2015
Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in ratPetra Vinken, William J Reagan, Luis A Rodriguez, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
IRB|October 23, 2003
Assessing benefits in clinical research: why diversity in benefit assessment can be riskyLarry R Churchill, Daniel K Nelson, Gail E Henderson, et al.
Clinical Pharmacology and Therapeutics|November 24, 2025
Biomarkers of Drug-Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug DevelopmentTanja S Zabka, Michael Lawton, Tom Chu, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
The Journal of Biological Chemistry|December 10, 2000
Subunit II of cytochrome c oxidase in Chlamydomonad algae is a heterodimer encoded by two independent nuclear genesX Pérez-Martínez, A Antaramian, M Vazquez-Acevedo, et al.
Circulation|July 9, 2004
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathySherif F Nagueh, Gopi Shah, Yiming Wu, et al.
Social Science & Medicine (1982)|July 8, 2005
Therapeutic misconception in early phase gene transfer trialsGail E Henderson, Michele M Easter, Catherine Zimmer, et al.
Database : the Journal of Biological Databases and Curation|February 2, 2026
predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugsJens Hansen, Pedro Martinez, Arjun S Yadaw, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Uncertain benefit: investigators' views and communications in early phase gene transfer trialsGail E Henderson, Arlene M Davis, Nancy M P King, et al.
American Journal of Nephrology|November 28, 2013
Perceptions regarding genetic testing in populations at risk for nephropathyBarry I Freedman, Alison J Fletcher, Vivek R Sanghani, et al.
Journal of Pharmacological and Toxicological Methods|October 31, 2015
Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in ratPetra Vinken, William J Reagan, Luis A Rodriguez, et al.
Pageof 14